Outcomes4Me Acquires Mika Health App to Enhance AI-Driven Cancer Care
Outcomes4Me has acquired the Mika Health app from Berlin-based Fosanis GmbH, as announced in a press release. The acquisition aims to enhance Outcomes4Me's AI-driven platform, which supports over 280,000 cancer patients, by integrating Mika's clinically validated interventions for symptom management and emotional support.
The Mika app, a certified medical device, has been used by more than 100,000 cancer patients globally. It is designed to help patients manage the physical and psychological effects of cancer through AI-driven emotional support and real-time symptom management. This acquisition will allow Outcomes4Me to scale its operations in European markets, leveraging Mika's regulatory readiness and local partnerships.
Maya R. Said, Founder and CEO of Outcomes4Me, stated that the acquisition is a significant step towards making cancer care more understandable and manageable for patients worldwide. The integration of Mika's technology is expected to set a new standard for digital oncology support, combining the strengths of both platforms to deliver comprehensive care solutions.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 31 AI Agent Controls Brain Injection in Live Mouse After Claude Opus Refuses Oct 31 Patient Sues Allegheny Health Network and Highmark Over Abridge AI Recordings Oct 31 OpenAI Releases GPT-Rosalind-6 for Approved Biology Researchers Oct 30 Surveys Find Widespread AI Chatbot Use Among Teens and Tweens Oct 30 Widow Sues OpenAI and Luka Over Husband's SuicideLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
MEDITECH and Lifemed AI Partner on Claims Automation
Azra AI Acquires Blackford Analysis
CureMD Earns ISO/IEC 42001 Certification for AI Management
POMDOCTOR Outlines Predictive Healthcare Strategy
AIRS Medical Gets FDA Clearance for MRI Body Composition Tool
Daily AI Brief: the AI news that matters, in your inbox.